Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas
A Pilot Study of Sutent®/Sunitinib (SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor in Subjects With NF-1 Plexiform Neurofibromas A Pilot Study of Sutent®/Sunitinib(SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor in Sub ...